11th Annual Houston Methodist Cancer Symposium - EXHIBIT REGISTRATION
You are NOT confirmed to exhibit until you register.
Dear Corporate Partner,
It is our pleasure to invite you to exhibit at our 11th Annual Houston Methodist Cancer Symposium hosted at the Houston Methodist Research Institute on Friday, August 11, 2023. On behalf of our Course Directors, Drs. Shilpan Shah and Eleni Efstathiou and the Office of Continuing Medical Education (CME) we graciously extend the opportunity for you to join us as an exhibitor and/or sponsor!
We estimate that this annual conference will attract approximately 100-150 in-person attendees and virtual attendees – all potential customers for your products and services.
I encourage you to take full advantage of this excellent opportunity to network with your target market as an exhibitor. Exhibiting companies will have the opportunity to share their educational materials and interact with participants.
Due to our limited number of exhibit openings, we hope you will take this opportunity and contact us now to register.
Please feel free to contact firstname.lastname@example.org if you have any questions or need additional information.
Shilpan Shah, MD
Assistant Professor, Clinical Medicine in Oncology
Weill Cornell Medical College
Adjunct Assistant Professor
Texas A&M University College of Medicine
Eleni Efstathiou, MD, PhD
of Genitourinary Medical Oncology
Houston Methodist Oncology Partners
Date and Time
Friday, August 11, 2023 | 8:00am – 4:45pm
Houston Methodist Research Institute
6670 Bertner Ave.
2nd Floor Pre-Function Space
Houston, TX 77030
EXHIBIT FEE: $1,350
- One 6’ x 3’ table-top exhibit with two chairs
- Exhibiting companies may send a maximum of two (2) representatives to staff their exhibit table.
- Recognition in the webpage and activity materials
NOTE: Companies may purchase one exhibit ONLY.
Physician scientists, practicing oncologists, advanced nurse practitioners and physician assistants, oncology nurses, residents, fellows, medical students, allied health personnel and clinical research associates will benefit from this course.
Upon completion of this course, the participant should be able to:
Discuss the fundamental mechanisms of cellular immunotherapy in hematologic malignancies
Describe the approved cell therapy options in hematologic malignancies including CAR-T cell
Identify new cellular therapies in the pipeline for these diseases
|8:15 AM||Welcome: Announcements and Introductions|
|8:30 AM||Solid Tumor Keynote: Topic TBD||Maha Hussain, MD, FACP, FASCO|
|9:15 AM||Question and Answer Session|
|9:25 AM||Whole-Body MRI – Past, Present and Future||Nakul Gupta, MD|
|9:55 AM||Question and Answer Session|
|10:00 AM||Break and Exhibits|
|10:25 AM||Biology-Driven De-Escalation of Therapy in HER2+ Breast Cancer||Polly A. Niravath, MD|
|10:55 AM||Question and Answer Session|
|11:00 AM||Novel Epigenetic Markers in Cell-free DNA of Cancer||Zejuan Li, MD, PhD, FACMG|
|11:30 AM||Question and Answer Session|
|11:35 AM||Lunch Keynote I: Voices Heard: Music Therapy Within Oncology||Sarah Rossi, MM, MT-BC|
|12:05 PM||Lunch Keynote II: TBD||TBD|
|12:35 PM||Lunch and Exhibits|
|1:00 PM||Hematology Keynote: Topic TBD||Joseph P. McGuirk, DO|
|1:45 PM||Question and Answer Session|
|1:55 PM||From Bench to Bedside: The History and Progress of CAR T-Cell Therapy||Bin He, PhD|
|2:25 PM||Question and Answer Session|
|2:30 PM||Break and Exhibits|
|2:45 PM||Tumor-Infiltrating Lymphocytes (TIL) for Clinicians||Siddhartha Ganguly, MD, FACP|
|3:15 PM||Question and Answer Session|
|3:20 PM||Break and Exhibits|
|3:40 PM||Abstract Winner Discussions|
|4:30 PM||Question and Answer Session|
We gratefully acknowledge the following companies for supporting our 11th Annual Houston Methodist Cancer Symposium:
Astellas Pharma, Inc.
Taiho Oncology, Inc.
- STEP 1 - Select the applicable fee and add to cart to complete the checkout process.
- STEP 2 - Once registered, on the week of the conference you will receive an email from Jalissa (email@example.com) for more details on exhibiting.